DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence

Phase 2

Completed

Conditions: Methamphetamine Dependence

Interventions: Other: Placebo
Drug: Bupropion

First Posted Date: 2008-06-02

Last Posted Date: 2017-03-21

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 200

Registration Number: NCT00687713

Locations: 🇺🇸
Matrix Institute, Woodland Hills, California, United States
🇺🇸
New York University, New York, New York, United States
🇺🇸
UCLA Integrated Substance Abuse Program, Los Angeles, California, United States

and more 9 locations

Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers

Phase 4

Completed

Conditions: Drug Abuse

Interventions: Behavioral: Reinforcement Based Treatment

First Posted Date: 2008-05-28

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 463

Registration Number: NCT00685620

Locations: 🇺🇸
Johns Hopkins Bayview, Baltimore, Maryland, United States

Vigabatrin Ph 1 Cocaine Interaction Study

Phase 1

Completed

Conditions: Cocaine Addiction

Interventions: Drug: Matching placebo
Drug: Vigabatrin

First Posted Date: 2008-02-29

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 24

Registration Number: NCT00626834

Locations: 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States

Effects of Smoking on Opioid Receptor Binding: A PET Study

Phase 1

Completed

Conditions: Substance-related Discorder

First Posted Date: 2008-02-20

Last Posted Date: 2018-04-05

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 26

Registration Number: NCT00618631

Locations: 🇺🇸
Johns Hopkins Medical Institute, Baltimore, Maryland, United States
🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

Sublingual Buprenorphine for Chronic Pain

Phase 2

Conditions: Chronic Pain

Interventions: Drug: buprenorphine

First Posted Date: 2008-02-11

Last Posted Date: 2009-04-07

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 40

Registration Number: NCT00612287

Locations: 🇺🇸
Beth Israel Medical Center, New York, New York, United States

Integration of the Therapeutic Workplace in Drug Court

Phase 1

Completed

Conditions: Drug Addiction

Interventions: Behavioral: Therapeutic Workplace Intervention

First Posted Date: 2008-02-05

Last Posted Date: 2017-01-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 59

Registration Number: NCT00607360

Chronic Hepatitis Intervention Project for Drug Users

Phase 3

Completed

Conditions: HIV
Hepatitis C

Interventions: Behavioral: Motivational interviewing
Behavioral: Educational intervention

First Posted Date: 2008-01-17

Last Posted Date: 2017-03-01

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 851

Registration Number: NCT00596843

Locations: 🇺🇸
RTI International Field Site, Durham, North Carolina, United States

A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder

Phase 1

Completed

Conditions: Bipolar Disorder

Interventions: Drug: Bupropion
Drug: Placebo

First Posted Date: 2008-01-14

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 5

Registration Number: NCT00593099

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

A Timeline Study of Alcohol Use and Its Relationship to Insomnia

Completed

Conditions: Insomnia
Alcohol Problem

First Posted Date: 2007-12-24

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 75

Registration Number: NCT00580411

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Motivation and Patch Treatment for HIV-positive Smokers

Phase 3

Completed

Conditions: HIV Infections
Smoking Cessation

Interventions: Behavioral: Standard Care
Behavioral: Motivational Enhancement

First Posted Date: 2007-10-31

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 444

Registration Number: NCT00551720

Locations: 🇺🇸
Rhode Island Hospital HIV Clinic, Providence, Rhode Island, United States
🇺🇸
Stanley Street Treatment and Resources, Inc., Fall River, Massachusetts, United States
🇺🇸
Greater New Bedford Community Center, New Bedford, Massachusetts, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy